Acceptability of the norplant subdermal implants

ABSTRACT

A total of 344 women was selected to evaluate the acceptability of norplant. Changes in the menstrual pattern were the most frequent side effects reported. However, such changes diminished with time and by the end of 12 months after insertion 7.1% of users experienced no change in cycle length and about 85% considered their menstrual pattern to be normal. Non-menstrual side effects were not persistent and not constituting a problem. The continuation rate was 86.337% and the pregnancy rate was 0.29/100 w.y., i.e. the continuation rate and the effectiveness are high